Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EXK - CA29258Y1034 - Common Stock

9.22 USD
-0.14 (-1.5%)
Last: 12/18/2025, 8:23:14 PM
9.29 USD
+0.07 (+0.76%)
Pre-Market: 12/19/2025, 7:10:04 AM
Fundamental Rating

2

Overall EXK gets a fundamental rating of 2 out of 10. We evaluated EXK against 156 industry peers in the Metals & Mining industry. EXK has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EXK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
EXK had a positive operating cash flow in the past year.
Of the past 5 years EXK 4 years were profitable.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of EXK (-9.27%) is worse than 71.15% of its industry peers.
Looking at the Return On Equity, with a value of -18.53%, EXK is doing worse than 69.23% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.08%, EXK is in line with its industry, outperforming 46.79% of the companies in the same industry.
EXK had an Average Return On Invested Capital over the past 3 years of 2.76%. This is significantly below the industry average of 13.25%.
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROIC 0.08%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

The Operating Margin of EXK (0.23%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXK has declined.
With a Gross Margin value of 13.03%, EXK perfoms like the industry average, outperforming 43.59% of the companies in the same industry.
EXK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.23%
PM (TTM) N/A
GM 13.03%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
Compared to 1 year ago, EXK has more shares outstanding
EXK has more shares outstanding than it did 5 years ago.
EXK has a worse debt/assets ratio than last year.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXK has an Altman-Z score of 2.83. This is not the best score and indicates that EXK is in the grey zone with still only limited risk for bankruptcy at the moment.
EXK has a Altman-Z score (2.83) which is in line with its industry peers.
EXK has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
EXK's Debt to Equity ratio of 0.23 is in line compared to the rest of the industry. EXK outperforms 45.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.83
ROIC/WACC0.01
WACC9.15%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 0.79. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
EXK has a worse Current ratio (0.79) than 91.03% of its industry peers.
EXK has a Quick Ratio of 0.79. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EXK (0.57) is worse than 87.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.57
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The earnings per share for EXK have decreased strongly by -66.67% in the last year.
EXK shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.22%.
EXK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%

3.2 Future

EXK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.69% yearly.
Based on estimates for the next years, EXK will show a very strong growth in Revenue. The Revenue will grow by 39.07% on average per year.
EPS Next Y-13.62%
EPS Next 2Y206.7%
EPS Next 3Y115.11%
EPS Next 5Y53.69%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 15.56, EXK is valued correctly.
EXK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXK is cheaper than 65.38% of the companies in the same industry.
EXK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 15.56
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

EXK's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 51.61
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as EXK's earnings are expected to grow with 115.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y206.7%
EPS Next 3Y115.11%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ENDEAVOUR SILVER CORP

NYSE:EXK (12/18/2025, 8:23:14 PM)

Premarket: 9.29 +0.07 (+0.76%)

9.22

-0.14 (-1.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners55.62%
Inst Owner Change19.01%
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap2.71B
Revenue(TTM)337.14M
Net Income(TTM)-94.29M
Analysts80
Price Target9.73 (5.53%)
Short Float %5.67%
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-354.6%
Min EPS beat(2)-595.05%
Max EPS beat(2)-114.14%
EPS beat(4)1
Avg EPS beat(4)-1434.73%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1023.35%
EPS beat(12)2
Avg EPS beat(12)-714.54%
EPS beat(16)3
Avg EPS beat(16)-577.87%
Revenue beat(2)2
Avg Revenue beat(2)8.49%
Min Revenue beat(2)0.04%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)16.94%
Revenue beat(8)7
Avg Revenue beat(8)2.97%
Revenue beat(12)9
Avg Revenue beat(12)1.92%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)0.56%
PT rev (3m)40.49%
EPS NQ rev (1m)-25.81%
EPS NQ rev (3m)53.33%
EPS NY rev (1m)-325%
EPS NY rev (3m)-376.92%
Revenue NQ rev (1m)2.09%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)5.52%
Revenue NY rev (3m)10.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.56
P/S 8.05
P/FCF N/A
P/OCF 57.74
P/B 5.33
P/tB 5.33
EV/EBITDA 51.61
EPS(TTM)-0.15
EYN/A
EPS(NY)0.59
Fwd EY6.43%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.16
OCFY1.73%
SpS1.15
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROCE 0.1%
ROIC 0.08%
ROICexc 0.08%
ROICexgc 0.08%
OM 0.23%
PM (TTM) N/A
GM 13.03%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 321.73%
Cap/Sales 52.32%
Interest Coverage 0.06
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.57
Altman-Z 2.83
F-Score3
WACC9.15%
ROIC/WACC0.01
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y-13.62%
EPS Next 2Y206.7%
EPS Next 3Y115.11%
EPS Next 5Y53.69%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%
EBIT growth 1Y-91.44%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year123.81%
EBIT Next 3Y140.25%
EBIT Next 5Y52.95%
FCF growth 1Y-134.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.01%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to EXK.


What is the valuation status for EXK stock?

ChartMill assigns a valuation rating of 2 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Overvalued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EXK stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to decline by -13.62% in the next year.